CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 36 enrolled
Drug / intervention
Ropivacaine +2 moredrug
Likely dose
Ropivacaine 5 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00672100
NCT00672100N/ACompleted

The Effect Of Initial Local Anesthetic Dose With Continuous Interscalene Analgesia On Postoperative Pain And Diaphragmatic Function In Arthroscopic Shoulder Surgery Patients: A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study

Corewell Health East·interventional·Posted May 6, 2008·Updated Mar 7, 2017

In Brief

A clinical study evaluating Ropivacaine for Post-operative Pain. Completed, enrolled 36 participants across 2 sites.

Detailed Summary

Objective: To determine a minimally effective initial local anesthetic bolus required to provide satisfactory analgesia using continuous brachial plexus infusion following arthroscopic shoulder surgery using a double-blind, randomized, study comparing 3 initial doses.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 6, 2008
Enrollment StartJan 1, 2009
Primary CompletionFeb 1, 2010
Study CompletionAug 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 18.2 years ago

Interventions

Ropivacainedrug

Initial Bolus 5 ml Ropivacaine via interscalene injection

Ropivacainedrug

Initial Bolus 10 ml Ropivacaine via interscalene injection

Ropivacainedrug

Initial Bolus 20 ml Ropivacaine via interscalene injection